BIOBIOME AUSTRALIA LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 July 2026, 18:40 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 19004, 19009 | |
| 27 July 2026, 19:34 | International Markets Presentation | Presentations | MS | 03026 | |
| 27 July 2026, 18:45 | Investor Webinar | Presentations | — | 12008, 14014 | |
| 1 July 2026, 18:35 | FY26 Trading Update | Other | MS | 03028 | |
| 26 June 2026, 18:43 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 June 2026, 03:41 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 June 2026, 03:34 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 11 June 2026, 18:53 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 June 2026, 18:37 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 3 June 2026, 18:43 | Biome Signs Australian Manufacturing Agreement | Company Update | MS | 11001 | |
| 3 June 2026, 18:38 | Biome Investor Presentation June 2026 | Presentations | — | 03026 | |
| 27 May 2026, 19:27 | Investor Webinar | Presentations | — | 14014 | |
| 27 May 2026, 18:43 | BMB18 clinical trial expands to dual site | Company Update | MS | 11001 | |
| 12 May 2026, 18:37 | Probiotical Exclusive Supply Agreement Extended | Company Update | MS | 11001 | |
| 30 Apr 2026, 19:23 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 29 Apr 2026, 19:29 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 29 Apr 2026, 02:45 | Revised Appendix 4C Quarterly Cash Flow Report | Quarterly Reports | — | 04003, 05003 | |
| 28 Apr 2026, 19:14 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 04003, 05003 | |
| 27 Apr 2026, 19:02 | Patent Application Filed for Probiotic Strain BMB18 | Company Update | MS | 11001 | |
| 11 Apr 2026, 03:11 | Change of Auditor | Other | — | 12018 | |
| 1 Apr 2026, 23:00 | Notification of cessation of securities - BIO | Other | — | 06027 | |
| 31 Mar 2026, 04:53 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 31 Mar 2026, 04:46 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 20 Mar 2026, 21:01 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 20 Mar 2026, 20:57 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 20 Mar 2026, 20:52 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 19 Mar 2026, 20:39 | Proposed issue of securities - BIO | Securities Administration | — | 06013 | |
| 18 Mar 2026, 05:02 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 18 Mar 2026, 04:57 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 13 Mar 2026, 19:26 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 13 Mar 2026, 04:10 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 13 Mar 2026, 04:06 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 10 Mar 2026, 19:25 | Expiry of Unlisted Options | Securities Administration | — | 06009 | |
| 25 Feb 2026, 19:26 | H1 FY26 Results & Company Presentation | Financial Results | — | 03004, 03026 | |
| 23 Feb 2026, 19:44 | Biome First Half FY26 Results and Highlights | Financial Results | MS | 03004 | |
| 23 Feb 2026, 19:22 | Appendix 4D & Half Yearly Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 19:14 | Biome Half Year Results and Webinar | Presentations | — | 03027, 14014 | |
| 3 Feb 2026, 19:17 | Ethics Approval Granted for BMB18 Human Clinical Trial | Company Update | MS | 11001 | |
| 2 Feb 2026, 19:20 | Biome secures distribution with Fullscript Canada | Company Update | MS | 11001 | |
| 27 Jan 2026, 19:46 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 19002, 19007 | |
| 5 Jan 2026, 19:37 | Trading Update | Other | MS | 03028 | |
| 15 Dec 2025, 19:23 | Biome Launches Human Clinical Trial on BMB18 | Company Update | MS | 11001 | |
| 4 Dec 2025, 19:37 | Biome appoints incoming Chief Financial Officer | Company Administration | — | 12008 | |
| 2 Dec 2025, 23:20 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 2 Dec 2025, 23:17 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 2 Dec 2025, 23:14 | Application for quotation of securities - BIO | Other | — | 06020 | |
| 28 Nov 2025, 00:03 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 27 Nov 2025, 01:29 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 24 Oct 2025, 21:15 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 17 Oct 2025, 19:29 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 19001, 19006 |
1–50 of 61
1 / 2